🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Texas medical center adopts Streamline Health's eValuator

EditorAhmed Abdulazez Abdulkadir
Published 07/02/2024, 07:45 AM
STRM
-

ATLANTA - Streamline Health Solutions, Inc. (NASDAQ:STRM), a provider of healthcare financial performance improvement solutions, has announced a contract with a Texas-based 750-bed medical center for the implementation of its eValuator software. The medical center, which utilizes Epic-EHR, will employ the pre-bill code auditing tool to enhance its revenue integrity.

eValuator's AI-powered technology assists healthcare providers in ensuring accurate capture and billing of services provided to patients, aiming to reduce the occurrence of denials. The software's TX-RAMP certification has opened the door for Streamline Health to engage with all Texas state-funded health systems.

Ben Stilwill, President and CEO of Streamline Health, expressed the company's commitment to expanding its client base and assisting health systems in securing accurate reimbursement for care delivered.

Streamline Health is recognized for offering integrated solutions and analytics that support healthcare organizations in addressing revenue loss and bolstering financial outcomes.

In other recent news, Streamline Health Solutions Inc. reported mixed Q1 results for fiscal 2024. The company's total revenue decreased to $4.3 million from $5.3 million in the same period last year. However, Streamline Health showed signs of resilience with a slight reduction in net loss and improvements in its adjusted EBITDA. The company has also executed private placements amounting to $4.5 million and reported cash on hand of $4 million as of April 30, 2024.

Pro forma SAS revenue, representing 63% of total revenue, grew by 22% after excluding non-renewed client revenue. The company aims for an adjusted EBITDA breakeven run rate in the second half of fiscal 2024 and is focusing on expanding its client base and enhancing product offerings. Management reported significant progress in implementations, with an increase of $1.5 million since last year's end.

The acquisition of RevID has improved their software model and scalability, and a direct partnership with Oracle (NYSE:ORCL) has been established. AI deployments have had a positive impact on clients, emphasizing the demand for AI in healthcare systems.

InvestingPro Insights

As Streamline Health Solutions, Inc. (NASDAQ:STRM) secures a new contract for its eValuator software, investors and industry observers are closely monitoring the company's financial health and stock performance. While the new partnership with the Texas-based medical center signifies progress in the company's business strategy, InvestingPro data and tips provide a more nuanced view of Streamline Health's current financial position and market dynamics.

The company's market capitalization stands at a modest $28.67 million, reflecting its position in the market. Despite recent business developments, analysts have expressed concern over Streamline Health's financial trajectory, anticipating a sales decline in the current year. This outlook is further substantiated by a revenue decrease of -11.08% over the last twelve months as of Q1 2023. Additionally, the company's stock price movements have been characterized as quite volatile, which could indicate a higher risk profile for potential investors.

InvestingPro data also reveals that Streamline Health's short-term obligations exceed its liquid assets, which may raise questions about the company's liquidity and ability to meet immediate financial commitments. Moreover, the firm's profitability remains under scrutiny, as analysts predict that the company will not be profitable this year, a trend that has been consistent over the last twelve months.

Despite these challenges, Streamline Health has experienced a strong return over the last month, with a 23.9% increase in its stock price. However, it is essential for potential investors to consider the company's broader financial context, including its lack of dividend payments to shareholders, which may influence investment decisions.

For those interested in a deeper analysis, InvestingPro offers additional insights, including a total of 7 InvestingPro Tips for Streamline Health, which can be accessed at https://www.investing.com/pro/STRM. To explore these tips and gain comprehensive investment analysis tools, readers can use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.